BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  Court Upholds Boston Scientific’s Win Over Stent Pioneer Dr. David Jang

  October 2, 2017

   · 

  1 min read
• Deals

  Why Abbott’s Torturous Alere Deal Drama Isn’t Over Yet

  October 2, 2017

   · 

  1 min read
• This U.S. Marijuana Stock Is Arguably The Best On The Market—And It’s Dirt Cheap

  October 2, 2017

   · 

  1 min read
• Policy

  Biotech Founded By Pharma Bro Shkreli Escapes $43 Million Lawsuit

  U.S. District Judge Edgardo Ramos in Manhattan said Vyera was liable for the money under its contract with Impax, but did not have to pay it because Impax had violated the contract as well.

  October 2, 2017

   · 

  1 min read
• Biotech Bay

  The Maker Of Botox Has Turned To The Oldest Trick In The Book To Save Its Cratering Stock

  October 2, 2017

   · 

  1 min read
• BioMidwest

  Sniff Test Predicts Dementia Developing Within Five Years, University of Chicago Study Reveals

  October 2, 2017

   · 

  1 min read
• Pharm Country

  Argentum Succeeds In Starting Patent Cancellation Trial Against Alcon’s TRAVATAN Z

  October 2, 2017

   · 

  2 min read
• Business

  SELLAS Life Sci Enters Into A Clinical Trial Collaboration And Supply Agreement With Merck & Co., Kenilworth, N.J., USA

  October 2, 2017

   · 

  8 min read
• Pharm Country

  Argentum Succeeds In Starting Patent Cancellation Trial Against Novartis AG’ AFINITOR

  October 2, 2017

   · 

  1 min read
• Pharm Country

  Mylan Launches Generic Gleevec Tablets

  October 2, 2017

   · 

  3 min read